Global Mitogen-Activated ERK Kinase (MEK) Inhibitors Market, By Target (MEK1, MEK2), Type (MEKINIST (Trametinib), COTELLIC (Cobimetinib), MEKTOVI (Binimetinib)), Application (NSCLC, Cancer, Others), Dosage (Tablets, Others), Route of Administration (Oral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) -  Industry Trends and Forecast to 2029.